Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of MF vs QMF149 in Pediatric Asthma
NCT04589663Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of atectura breezhaler in asthma, sponsored by Novartis. Started Jun 2021; status: completed.
02
Drugs
atectura breezhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04589663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589663.